Inicio de sesión

Por favor, inicia sesión para acceder al contenido

¿Olvidó su contraseña??


Weight management and T2D: Approaches to prevent co-morbidities and improve quality of life

An Adaptive Learning Course for Primary Care Physicians

Coming soon! A brand-new adaptive learning program featuring content from the Endocrine Society entitled Weight management and T2D: approaches to prevent co-morbidities and improve quality of life is currently in development.

Prof Donna Ryan, former President of the World Obesity Foundation, has helped create pathways to new knowledge for PCPS and other healthcare professionals that care for people living with T2D.  

Take the pre-assessment quiz to test your knowledge

What You Will Learn:

  • What obesity really is
  • Metabolically healthy obesity
  • Benefits of weight loss
  • Strategies for weight loss
  • Tips for primary care
  • The role of effective communication

And much more!

Who is this course for?  This activity is designed for primary care physicians who treat people with type 2 diabetes worldwide. Other healthcare professionals involved in the care of people with type 2 diabetes may also benefit from this course.

Conflict of Interest Statement  Infomedica pays special attention to issues of independence and potential bias to maintain the integrity of its educational programs. All individuals in a position to influence the contents of this program have disclosed any financial relationship with organizations. Infomedica has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant relationships are listed below. All individuals not listed have no relevant financial relationships.

Prof Donna Ryan, discloses the following:
Advisor/consultant: Altimmune, Amgen, Calibrate, Carmot, Epitomee, Gila, Lilly, Novo Nordisk, Scientific Intake, Wondr Health, Xeno Bioscience, YSOPIA, Zealand; 
Speaker’s Bureau: Novo Nordisk; Stock Options: Epitome, Calibrate, Roman, Scientific Intake; 
Research: SELECT Steering Committee (Novo Nordisk) and DSMB (Rhythm).

Disclaimer The views and opinions expressed in this activity are those of the faculty.


This activity is supported by an educational grant from Lilly.